Viloxazine (trade name Qelbree) is a new non-stimulant ADHD medication. It�s an anti-depressant, like atomoxetine (Straterra), which it will probably replace because it is more effective (it affects more neurotransmitters) and has a lower frequency of side effects. That�s...
Viloxazine (trade name Qelbree) is a new non-stimulant ADHD medication. It�s an anti-depressant, like atomoxetine (Straterra), which it will probably replace because it is more effective (it affects more neurotransmitters) and has a lower frequency of side effects. That�s all good. It may even replace some of the stimulants, which are the most effective meds, but aren�t the best for some people for various reasons. It�s� presumably non-addictive and nonabusable. It may be a great resource in this time of shortage of the stimulants.
Now for the bad news; it seems to currently cost about $10 a pill.
My Comment O the Day:
The article announcing this was a little biased, over emphasizing the possible side effects of stimulants. While I know there have been problems, I have never personally seen one. The non-stimulants also have their own problems. However, this new medication appears very promising.
Question O the Day:
If I did all the things I�m supposed to do for my health, would I have time to do anything else?
(and would I have to eat Brussel sprouts, kale, and broccoli?)
doug
#ADHD #adultADHD
ADHDMEds
